|
|
Article: Pentostatin shows promise for treatment of refractory chronic GVHD in children.
- Article from:
- Health & Medicine Week
- Article date:
- September 8, 2003
CopyrightCOPYRIGHT 2003 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
2003 SEP 8 - (NewsRx.com & NewsRx.net) -- Pentostatin shows promise for the treatment of chronic graft-versus-host reactions in pediatric stem cell transplant recipients.
"Chronic graft-versus-host disease (cGVHD) is a major barrier to successful allogeneic stem cell transplantation," scientists in the United States explained. "Pentostatin has been used to treat cGVHD in a small series of pediatric patients."
J.D. Goldberg and colleagues described "the results of the first five pediatric patients receiving pentostatin for refractory cGVHD at Johns Hopkins Hospital."
"In this early experience, the authors saw considerable symptom response in ...